{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:22:43Z","timestamp":1747200163721,"version":"3.40.5"},"reference-count":57,"publisher":"Media Sphere Publishing House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rus. Bull. Otorhino."],"published-print":{"date-parts":[[2023,5,15]]},"abstract":"<jats:p>Annotation. Dornase alfa (Pulmozyme, Tigerase) is a purified solution of recombinant human DNase, clinically developed for the treatment of pulmonary diseases in patients with cystic fibrosis (CF). The action of the drug is aimed at destroying the viscous secretion, rich in DNA strands of neutrophils, through their fragmentation, the density of the secretion decreases, and the aeration of the lower respiratory tract improves. The similarity of pathological processes with the formation of viscous exudate on the surface of the mucous membrane in diseases of the upper respiratory tract and ear initiated studies on the use of Dornase alpha in otorhinolaryngology. Material and methods. The analysis of materials of domestic and foreign authors on the effectiveness of the use of the drug Dornase alfa in otorhinolaryngology was carried out. Results. The review included 132 patients (10 studies) in whom Dornase alfa was used to treat CF-associated nasal and paranasal sinus diseases. Analysis of the literature revealed only 3 studies, one of which consisted of two parts, examining the effect of Dornase alpha on middle ear exudate: two studies were demonstrated in an animal model; one \u2014 in vitro on samples of middle ear effusion which were aspirated through a myringotomy incision from patients with recurrent acute otitis media; and one in clinical 40 patients (40 ears) for hydrolysis of exudate in the tympanostomy tubes. Conclusion. Analysis of studies on the use of Dornase alfa demonstrates an improvement in clinical symptoms in all patients with CF and chronic rhinosinusitis. In experimental studies on an animal model, as well as in vitro research on exudate from the middle ear, Dornase alfa has demonstrated high efficacy and safety. Dornase alfa is a drug with high potential, further research is needed for wider use in ENT practice, especially in otiatrics.<\/jats:p>","DOI":"10.17116\/otorino20228802159","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:03:01Z","timestamp":1684162981000},"page":"59","source":"Crossref","is-referenced-by-count":0,"title":["Possibilities of using recombinant human deoxyribonuclease I in otorhinolaryngology"],"prefix":"10.17116","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-2415","authenticated-orcid":false,"given":"K.V.","family":"Eremeeva","sequence":"first","affiliation":[{"name":"Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1257-9879","authenticated-orcid":false,"given":"V.M.","family":"Svistushkin","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-5977","authenticated-orcid":false,"given":"E.V.","family":"Sinkov","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3877-0935","authenticated-orcid":false,"given":"A.R.","family":"Mironova","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7372-3299","authenticated-orcid":false,"given":"V.P.","family":"Sobolev","sequence":"additional","affiliation":[{"name":"Sechenov First Moscow State Medical University","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/otorino20228802159-1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2008.7"},{"key":"key-10.17116\/otorino20228802159-2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-2920.2011.02459.x"},{"key":"key-10.17116\/otorino20228802159-3","doi-asserted-by":"crossref","unstructured":"Simonova OI, Lukina OF. Dornase alfa In Russia: 15 years later. Efficacy of the drug in the basic treatment in children with cystic fibrosis. Current Pediatrics. 2012;11(2):132-139. (In Russ.). Accessed September 26, 2021. https:\/\/www.researchgate.net\/publication\/286434105_dornaza_alfa_v_rossii_15_let_spusta_effektivnost_preparata_v_bazisnoj_terapii_u_detej_s_mukoviscidozom","DOI":"10.15690\/vsp.v11i2.226"},{"key":"key-10.17116\/otorino20228802159-4","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200519030-00001"},{"key":"key-10.17116\/otorino20228802159-5","doi-asserted-by":"publisher","DOI":"10.1097\/mcp.0b013e328358d51f"},{"key":"key-10.17116\/otorino20228802159-6","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9525(89)90156-x"},{"key":"key-10.17116\/otorino20228802159-7","doi-asserted-by":"publisher","DOI":"10.1016\/0168-9525(89)90155-8"},{"key":"key-10.17116\/otorino20228802159-8","doi-asserted-by":"publisher","DOI":"10.17116\/otorino201681515-18"},{"key":"key-10.17116\/otorino20228802159-9","doi-asserted-by":"publisher","DOI":"10.17116\/otorino20218604159"},{"key":"key-10.17116\/otorino20228802159-10","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20409"},{"key":"key-10.17116\/otorino20228802159-11","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23656"},{"key":"key-10.17116\/otorino20228802159-12","doi-asserted-by":"publisher","DOI":"10.1186\/cc3544"},{"key":"key-10.17116\/otorino20228802159-13","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.131.12.1097"},{"key":"key-10.17116\/otorino20228802159-14","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.1950200509"},{"key":"key-10.17116\/otorino20228802159-15","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1099-0496(199901)27:1<59::aid-ppul11>3.0.co;2-d"},{"key":"key-10.17116\/otorino20228802159-16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.05.014"},{"key":"key-10.17116\/otorino20228802159-17","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.365"},{"key":"key-10.17116\/otorino20228802159-18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012740"},{"key":"key-10.17116\/otorino20228802159-19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2282"},{"key":"key-10.17116\/otorino20228802159-20","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu357xx"},{"key":"key-10.17116\/otorino20228802159-21","doi-asserted-by":"publisher","DOI":"10.1191\/096120399678847380"},{"key":"key-10.17116\/otorino20228802159-22","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2011.113"},{"key":"key-10.17116\/otorino20228802159-23","doi-asserted-by":"publisher","DOI":"10.2196\/preprints.20121"},{"key":"key-10.17116\/otorino20228802159-24","unstructured":"Amelina EL, Kashirskaya NYu, Shmarina GV, Krasovskiy SA, Kudlay DA, Markova OA, Avdeev SN. Dornase alfa in the treatment of COVID-19: destruction of neutrophil extracellular traps. Pulmonologiya. 2020;30(3):344-349. (In Russ.). Accessed September 26, 2021. https:\/\/www.generium.ru\/upload\/preparations\/tigeraza\/%D0%94%D0%BE%D1%80%D0%BD%D0%B0%D0%B7%D0%B0%20%D0%B0%D0%BB%D1%8C%D1%84%D0%B0%20%D0%B2%20%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B8%20COVID-19.pdf"},{"key":"key-10.17116\/otorino20228802159-25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100689"},{"key":"key-10.17116\/otorino20228802159-26","unstructured":"Martynova IV, Karpova EP, Kapranov NI. Peculiarities of ent-damage in children with cystic fibrosis. Current Pediatrics. 2011;10(5):49-53. (In Russ.). Accessed September 26, 2021. https:\/\/cyberleninka.ru\/article\/n\/osobennosti-porazheniya-lor-organov-u-detey-s-mukovistsidozom\/viewer"},{"key":"key-10.17116\/otorino20228802159-27","unstructured":"Martynova IV. Features of Chronic Rhinosinusitis And its Clinical Significance in The Pathology of Lower Respiratory Tract Infections in Children with Cystic Fibrosis: Diss. ... kand. med. nauk. M. 2012. (In Russ.). Accessed September 26, 2021. https:\/\/fnkc.ru\/pdf\/diss\/arhiv-ar\/martynova.pdf"},{"key":"key-10.17116\/otorino20228802159-28","doi-asserted-by":"publisher","DOI":"10.24110\/0031-403X-2019-98-6-111-117"},{"key":"key-10.17116\/otorino20228802159-29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd001127.pub4"},{"key":"key-10.17116\/otorino20228802159-30","unstructured":"The in vitro mucolytic effect of xylitol and dornase alfa on chronic rhinosinusitis mucus. Vestnik otorinolaringologii. 2017;82(6):89. (In Russ.). Accessed December 09, 2021. https:\/\/www.mediasphera.ru\/issues\/vestnik-otorinolaringologii\/2017\/6\/1004246682017061089?sphrase_id=106388"},{"key":"key-10.17116\/otorino20228802159-31","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22082"},{"key":"key-10.17116\/otorino20228802159-32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2014.02.005"},{"key":"key-10.17116\/otorino20228802159-33","doi-asserted-by":"publisher","DOI":"10.1016\/j.anl.2010.09.001"},{"key":"key-10.17116\/otorino20228802159-34","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21584"},{"key":"key-10.17116\/otorino20228802159-35","doi-asserted-by":"publisher","DOI":"10.1016\/s1569-1993(10)60089-6"},{"key":"key-10.17116\/otorino20228802159-36","doi-asserted-by":"publisher","DOI":"10.1016\/s1569-1993(13)60361-6"},{"key":"key-10.17116\/otorino20228802159-37","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(11)60395-0"},{"key":"key-10.17116\/otorino20228802159-38","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.22682"},{"key":"key-10.17116\/otorino20228802159-39","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.126.5.581"},{"key":"key-10.17116\/otorino20228802159-40","unstructured":"Shumkova GL. Osobennosti patologii nosa i okolonosovykh pazukh u vzroslykh bol\u2019nykh mukovistsidozom: rasprostranennost\u2019, klinicheskoe techenie i taktika vedeniya: Diss. ... kand. med. nauk. M. 2020. (In Russ.). Accessed September 26, 2021. https:\/\/www.sechenov.ru\/upload\/iblock\/856\/DISSERTATSIYA-SHumkova.pdf"},{"key":"key-10.17116\/otorino20228802159-41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053837"},{"key":"key-10.17116\/otorino20228802159-42","doi-asserted-by":"publisher","DOI":"10.1128\/iai.01104-13"},{"key":"key-10.17116\/otorino20228802159-43","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2018.1101"},{"key":"key-10.17116\/otorino20228802159-44","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.2003.00677.x"},{"key":"key-10.17116\/otorino20228802159-45","doi-asserted-by":"publisher","DOI":"10.1177\/194589240201600306"},{"key":"key-10.17116\/otorino20228802159-46","doi-asserted-by":"publisher","DOI":"10.18692\/1810-4800-2018-6-56-63"},{"key":"key-10.17116\/otorino20228802159-47","doi-asserted-by":"publisher","DOI":"10.1177\/0194599811407279"},{"key":"key-10.17116\/otorino20228802159-48","doi-asserted-by":"publisher","DOI":"10.1177\/194589240501900108"},{"key":"key-10.17116\/otorino20228802159-49","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(98)70344-0"},{"key":"key-10.17116\/otorino20228802159-50","unstructured":"Rusetsky YuYu, Simonova OI, Polunina TA, Malyavina US, Latysheva EN, Namazova-Baranova LS. Paranasal sinuses state in children with cystic fibrosis. Pediatria. 2017;96(2):144-150. (In Russ.). Accessed September 26, 2021. https:\/\/cyberleninka.ru\/article\/n\/sostoyanie-okolonosovyh-pazuh-u-detey-s-mukovistsidozom\/viewer"},{"key":"key-10.17116\/otorino20228802159-51","doi-asserted-by":"publisher","DOI":"10.21518\/2079-701X-2019-8-48-53"},{"key":"key-10.17116\/otorino20228802159-52","unstructured":"David TJ. Nasal polyposis, opaque paranasal sinuses and usually normal hearing: the otorhinolaryngological features of cystic fibrosis. J R Soc Med. 1986;79(Suppl 12):23-26. Accessed September 26, 2021.  https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC1290122\/?page=1"},{"key":"key-10.17116\/otorino20228802159-53","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1970.04310010080009"},{"key":"key-10.17116\/otorino20228802159-54","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1979.00790180036007"},{"key":"key-10.17116\/otorino20228802159-55","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1971.00770060143028"},{"key":"key-10.17116\/otorino20228802159-56","unstructured":"Barilyak VV. Status hearing in children with cystic fibrosis: Diss. ... kand. med. nauk. M. 2012. (In Russ.). Accessed September 26, 2021. https:\/\/rusneb.ru\/catalog\/000199_000009_005012946"},{"key":"key-10.17116\/otorino20228802159-57","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103067"}],"container-title":["Russian Bulletin of Otorhinolaryngology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T14:07:40Z","timestamp":1745503660000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/vestnik-otorinolaringologii\/2023\/2\/1004246682023021059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5,15]]}},"alternative-id":["10.17116\/otorino20228802159"],"URL":"https:\/\/doi.org\/10.17116\/otorino20228802159","relation":{},"ISSN":["0042-4668"],"issn-type":[{"type":"print","value":"0042-4668"}],"subject":[],"published":{"date-parts":[[2023,5,15]]}}}